Table of Contents:
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size by Treatment Type
2.3.2 Market Size by Type
2.3.3 Market Size by Allergy Type
2.3.4 Market Size by Distribution Channel
2.4 Market Share & Bps Analysis by Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material & Technology Providers
3.4.2 Test Kit & Platform Manufacturers
3.4.3 Distributors & Service Providers
3.4.4 End Users / Healthcare Facilities
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Allergy Prevalence & Disease Burden Trends (2025)
4.1.1 Global Incidence of Allergic Rhinitis, Asthma & Food Allergies
4.1.2 Pediatric vs. Adult Allergy Prevalence Trends
4.1.3 Seasonal & Environmental Allergy Pattern Analysis
4.1.4 Regional Allergy Burden & Urbanization Impact Trends
4.2 Immunotherapy Treatment Adoption Trends (2025)
4.2.1 Subcutaneous Immunotherapy (SCIT) vs. Sublingual Immunotherapy (SLIT) Adoption
4.2.2 Growth in Personalized Allergy Treatment Approaches
4.2.3 Home-Based vs. Clinic-Based Therapy Trends
4.2.4 Long-Term Patient Compliance & Therapy Continuation Rates
4.3 Diagnostic & Clinical Workflow Trends (2025)
4.3.1 Allergy Diagnostic Testing Utilization Trends
4.3.2 Biomarker & Precision Medicine Integration in Immunotherapy
4.3.3 Digital Monitoring & Tele-Allergy Consultation Adoption
4.3.4 Clinical Trial Activity in Novel Allergy Immunotherapies
4.4 Healthcare Spending & Reimbursement Trends (2025)
4.4.1 Public vs. Private Spending on Allergy Treatments
4.4.2 Insurance Coverage & Reimbursement Trends for Immunotherapy
4.4.3 Investments in Allergy Clinics & Specialized Care Centers
4.4.4 Pharmaceutical R&D Spending on Allergy Therapeutics
4.5 Technology, Innovation & Regulatory Trends (2025)
4.5.1 Advancements in Recombinant & Peptide-Based Immunotherapies
4.5.2 Regulatory Approvals for Novel Allergy Treatments
4.5.3 AI & Digital Platforms in Allergy Management
4.5.4 Patent Filings & Innovation Trends in Allergy Immunotherapy Solutions
5. Allergy Immunotherapy Market Segmental Analysis & Forecast, By Treatment Type, 2022 – 2035, Value (USD Billion)
5.1 Introduction
5.2 Subcutaneous Immunotherapy (SCIT)
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2035
5.3 Sublingual Immunotherapy (SLIT)
6. Allergy Immunotherapy Market Segmental Analysis & Forecast, By Type, 2022 – 2035, Value (USD Billion)
6.1 Introduction
6.2 Tablets
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2035
6.3 Drops
7. Allergy Immunotherapy Market Segmental Analysis & Forecast, By Allergy Type, 2022 – 2035, Value (USD Billion)
7.1 Introduction
7.2 Allergic Rhinitis
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2035
7.3 Allergic Asthma
7.4 Food Allergy
7.5 Others
8. Allergy Immunotherapy Market Segmental Analysis & Forecast, By Distribution Channel, 2022 – 2035, Value (USD Billion)
8.1 Introduction
8.2 Hospital Pharmacy
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2035
8.3 Retail Pharmacy
8.4 Online Pharmacy
9. Allergy Immunotherapy Market Segmental Analysis & Forecast by Region, 2022 – 2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Allergy Immunotherapy Market Size & Forecast, By Treatment Type, 2022 – 2035
9.2.3 Allergy Immunotherapy Market Size & Forecast, By Type, 2022 – 2035
9.2.4 Allergy Immunotherapy Market Size & Forecast, By Allergy Type, 2022 – 2035
9.2.5 Allergy Immunotherapy Market Size & Forecast, By Distribution Channel, 2022 – 2035
9.2.6 Allergy Immunotherapy Market Size & Forecast, By Country, 2022 – 2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Allergy Immunotherapy Market Size & Forecast, By Treatment Type, 2022 – 2035
9.3.3 Allergy Immunotherapy Market Size & Forecast, By Type, 2022 – 2035
9.3.4 Allergy Immunotherapy Market Size & Forecast, By Allergy Type, 2022 – 2035
9.3.5 Allergy Immunotherapy Market Size & Forecast, By Distribution Channel, 2022 – 2035
9.3.6 Allergy Immunotherapy Market Size & Forecast, By Country, 2022 – 2035
9.3.6.1 Germany
9.3.6.2 United Kingdom
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Allergy Immunotherapy Market Size & Forecast, By Treatment Type, 2022 – 2035
9.4.3 Allergy Immunotherapy Market Size & Forecast, By Type, 2022 – 2035
9.4.4 Allergy Immunotherapy Market Size & Forecast, By Allergy Type, 2022 – 2035
9.4.5 Allergy Immunotherapy Market Size & Forecast, By Distribution Channel, 2022 – 2035
9.4.6 Allergy Immunotherapy Market Size & Forecast, By Country, 2022 – 2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Allergy Immunotherapy Market Size & Forecast, By Treatment Type, 2022 – 2035
9.5.3 Allergy Immunotherapy Market Size & Forecast, By Type, 2022 – 2035
9.5.4 Allergy Immunotherapy Market Size & Forecast, By Allergy Type, 2022 – 2035
9.5.5 Allergy Immunotherapy Market Size & Forecast, By Distribution Channel, 2022 – 2035
9.5.6 Allergy Immunotherapy Market Size & Forecast, By Country, 2022 – 2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Allergy Immunotherapy Market Size & Forecast, By Treatment Type, 2022 – 2035
9.6.3 Allergy Immunotherapy Market Size & Forecast, By Type, 2022 – 2035
9.6.4 Allergy Immunotherapy Market Size & Forecast, By Allergy Type, 2022 – 2035
9.6.5 Allergy Immunotherapy Market Size & Forecast, By Distribution Channel, 2022 – 2035
9.6.6 Allergy Immunotherapy Market Size & Forecast, By Country, 2022 – 2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2022 – 2025
10.2.3 Number of Strategies Adopted by Key Players, 2025
10.3 Market Share Analysis, 2025
10.4 Product/Service & Network Type Benchmarking
10.4.1 Product/Service Specifications & Features by Key Players
10.4.2 Product/Service Heatmap by Key Players
10.4.3 Network Type Heatmap by Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 ALK-Abelló A/S
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 XVIVO Perfusion AB
10.6.2 Stallergenes Greer plc
10.6.3 Allergy Therapeutics plc
10.6.4 HAL Allergy B.V.
10.6.5 Merck KGaA
10.6.6 DBV Technologies
10.6.7 Aimmune Therapeutics (Nestlé Health Science)
10.6.8 Regeneron Pharmaceuticals, Inc.
10.6.9 Sanofi S.A.
10.6.10 Novartis AG / Genentech (Roche)
10.6.11 Biomay AG
10.6.12 Torii Pharmaceutical Co., Ltd.
10.6.13 Zydus Lifesciences Ltd
10.6.14 Cipla Ltd.
10.6.15 LETI Pharma
10.6.16 Bencard Allergie GmbH
10.6.17 Alk-Scherax Arzneimittel GmbH
10.6.18 Circassia Group plc
10.6.19 Mylan N.V. (Viatris)
10.6.20 Adamis Pharmaceuticals Corporation
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List of Tables
14.2 List of Figures
Frequently Asked Questions
Ans: The Allergy Immunotherapy Market is expected to grow at a CAGR of 9.5% from 2026 to 2035.
Ans: The Allergy Immunotherapy Market was valued at USD 2.1 billion in 2025.
Ans: Favorable regulatory approvals and an expanding product pipeline - encompassing SLIT tablet approvals, food allergy OIT and biologic therapies, and landmark approvals such as the FDA's clearance of omalizumab for multi-food allergy protection - are the primary structural growth drivers, alongside the escalating global burden of allergic diseases affecting an estimated 30–40% of the world's population.
Ans: Subcutaneous Immunotherapy (SCIT) dominated the Allergy Immunotherapy Market in 2025 with approximately 65% of global revenue, owing to its decades of clinical validation as the gold standard for severe allergic disease management, strong physician adoption, and established insurance reimbursement infrastructure across North America and Europe.
Ans: North America dominated the Allergy Immunotherapy Market in 2025, accounting for approximately 38% of global market revenue, driven by the high prevalence of allergic diseases in the U.S., advanced FDA regulatory frameworks for both SCIT and SLIT products, strong allergist clinical network infrastructure, and robust insurance reimbursement policies for immunotherapy treatment protocols.
Get in Touch
